SEC Company Response from aTYR PHARMA INC (ATYR) (CIK 0001339970) (ATYR) — May 4, 2015
aTYR PHARMA INC (ATYR) (CIK 0001339970)
Date: May 4, 2015 · CIK: 0001339970 · Accession: 0001193125-15-169181
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-203272
Letter
J.P. Morgan Securities LLC
383 Madison Avenue
New York, NY 10179
Citigroup Global Markets Inc.
388 Greenwich Street
New York, New York 10013
May 4, 2015
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549-3720
Attention:
Jeffrey P. Riedler, Assistant Director
Bryan J. Pitko
Matthew Jones
Re: aTyr Pharma, Inc.
Registration Statement on Form S-1
Filed on April 6, 2015
Registration File No. 333-203272
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), the undersigned, as representatives of the several underwriters (the “Underwriters”), hereby join in the request of aTyr Pharma, Inc. (the “Company”) for acceleration of the effective date of the above-referenced registration statement so that it becomes effective at 4:00 p.m., Eastern time, on May 6, 2015, or as soon thereafter as practicable.
Pursuant to Rule 460 under the Act, we, as representatives of the several underwriters, wish to advise you that we have effected the following distribution of the Company’s Preliminary Prospectus dated April 27, 2015:
(i) Dates of distribution: April 27, 2015 through the date hereof
(ii) Number of prospective underwriters to which the preliminary prospectus was furnished: 4
(iii) Number of prospectuses furnished to investors: approximately 646
(iv) Number of prospectuses distributed to others, including the Company, the Company’s counsel, independent accountants, and underwriters’ counsel: approximately 40
The undersigned advise that they have complied and will continue to comply, and each Underwriter and dealer has advised the undersigned that it has complied and will continue to comply, with Rule 15c2-8 under the Securities Exchange Act of 1934.
[Signature page follows]
Very truly yours,
J.P. MORGAN SECURITIES LLC
Show Raw Text
CORRESP 1 filename1.htm CORRESP J.P. Morgan Securities LLC 383 Madison Avenue New York, NY 10179 Citigroup Global Markets Inc. 388 Greenwich Street New York, New York 10013 May 4, 2015 Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549-3720 Attention: Jeffrey P. Riedler, Assistant Director Bryan J. Pitko Matthew Jones Re: aTyr Pharma, Inc. Registration Statement on Form S-1 Filed on April 6, 2015 Registration File No. 333-203272 Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), the undersigned, as representatives of the several underwriters (the “Underwriters”), hereby join in the request of aTyr Pharma, Inc. (the “Company”) for acceleration of the effective date of the above-referenced registration statement so that it becomes effective at 4:00 p.m., Eastern time, on May 6, 2015, or as soon thereafter as practicable. Pursuant to Rule 460 under the Act, we, as representatives of the several underwriters, wish to advise you that we have effected the following distribution of the Company’s Preliminary Prospectus dated April 27, 2015: (i) Dates of distribution: April 27, 2015 through the date hereof (ii) Number of prospective underwriters to which the preliminary prospectus was furnished: 4 (iii) Number of prospectuses furnished to investors: approximately 646 (iv) Number of prospectuses distributed to others, including the Company, the Company’s counsel, independent accountants, and underwriters’ counsel: approximately 40 The undersigned advise that they have complied and will continue to comply, and each Underwriter and dealer has advised the undersigned that it has complied and will continue to comply, with Rule 15c2-8 under the Securities Exchange Act of 1934. [Signature page follows] Very truly yours, J.P. MORGAN SECURITIES LLC CITIGROUP GLOBAL MARKETS INC. Acting severally on behalf of themselves and the several Underwriters By: J.P. MORGAN SECURITIES LLC By: /s/ Phillip Ross Name: Phillip Ross Title: Managing Director By: CITIGROUP GLOBAL MARKETS INC. By: /s/ Jennifer Jarrett Name: Jennifer Jarrett Title: Managing Director [Signature page to Underwriters’ Acceleration Request]